Medicine & Life Sciences
Primary Myelofibrosis
100%
Lenalidomide
67%
Paroxysmal Hemoglobinuria
51%
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
47%
Coronavirus
46%
ixazomib
42%
Anemia
39%
Multiple Myeloma
36%
Hemophagocytic Lymphohistiocytosis
32%
von Willebrand Factor
30%
Bortezomib
30%
Rituximab
27%
Lymphoma, Large B-Cell, Diffuse
27%
MLN2238
26%
Dexamethasone
25%
Therapeutics
25%
gossypol acetic acid
25%
Pulmonary Embolism
24%
Venous Thrombosis
23%
Prednisone
22%
Platelet Glycoprotein GPIb-IX Complex
22%
pomalidomide
22%
Megakaryocytes
22%
Gray Platelet Syndrome
22%
Plasma Cells
22%
tipifarnib
21%
ponatinib
20%
Bernard-Soulier Syndrome
20%
Aplastic Anaemia
19%
Factor VII Deficiency
19%
Bone Marrow Failure Disorders
19%
HLA-DR2 Antigen
19%
Klippel-Trenaunay-Weber Syndrome
19%
Heart Valve Prosthesis
18%
Survival
18%
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
17%
Platelet Activation
16%
Leukemia, Myeloid, Chronic Phase
16%
Waldenstrom Macroglobulinemia
16%
Blast Crisis
16%
Clone Cells
16%
Essential Thrombocythemia
16%
Hepcidins
16%
Drug Therapy
16%
Phenotype
16%
Progression-Free Survival
15%
Polycythemia
15%
Polycythemia Vera
15%
Sildenafil Citrate
15%
factor VIII, von Willebrand factor drug combination
15%